Saint Vincent and the Grenadines

Saint Vincent and the Grenadines

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.52 (0.44 - 0.61) 2019 Modelled IHME
0.54 (0.45 - 0.63) 2018 Modelled IHME
0.55 (0.46 - 0.64) 2017 Modelled IHME
0.55 (0.47 - 0.63) 2016 Modelled IHME
0.55 (0.47 - 0.64) 2015 Modelled IHME
0.56 (0.47 - 0.64) 2014 Modelled IHME
0.57 (0.48 - 0.66) 2013 Modelled IHME
0.58 (0.48 - 0.67) 2012 Modelled IHME
0.59 (0.48 - 0.69) 2011 Modelled IHME
0.6 (0.49 - 0.71) 2010 Modelled IHME
0.62 (0.50 - 0.73) 2009 Modelled IHME
0.63 (0.51 - 0.75) 2008 Modelled IHME
0.65 (0.53 - 0.77) 2007 Modelled IHME
0.66 (0.54 - 0.79) 2006 Modelled IHME
0.67 (0.55 - 0.80) 2005 Modelled IHME
0.68 (0.56 - 0.80) 2004 Modelled IHME
0.68 (0.56 - 0.80) 2003 Modelled IHME
0.68 (0.56 - 0.81) 2002 Modelled IHME
0.69 (0.57 - 0.81) 2001 Modelled IHME
0.69 (0.57 - 0.81) 2000 Modelled IHME
0.69 (0.58 - 0.81) 1999 Modelled IHME
0.7 (0.58 - 0.81) 1998 Modelled IHME
0.7 (0.59 - 0.82) 1997 Modelled IHME
0.71 (0.59 - 0.83) 1996 Modelled IHME
0.71 (0.58 - 0.83) 1995 Modelled IHME
0.71 (0.59 - 0.83) 1994 Modelled IHME
0.71 (0.59 - 0.84) 1993 Modelled IHME
0.71 (0.59 - 0.84) 1992 Modelled IHME
0.71 (0.58 - 0.84) 1991 Modelled IHME
0.71 (0.58 - 0.85) 1990 Modelled IHME
1.33 (0.17 - 9.83) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.03) 2019 Modelled IHME
0.02 (0.01 - 0.02) 2018 Modelled IHME
0.02 (0.01 - 0.02) 2017 Modelled IHME
0.02 (0.01 - 0.03) 2016 Modelled IHME
0.02 (0.01 - 0.03) 2015 Modelled IHME
0.02 (0.01 - 0.03) 2014 Modelled IHME
0.02 (0.02 - 0.03) 2013 Modelled IHME
0.02 (0.02 - 0.03) 2012 Modelled IHME
0.02 (0.02 - 0.03) 2011 Modelled IHME
0.02 (0.02 - 0.03) 2010 Modelled IHME
0.03 (0.02 - 0.04) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.04 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.06) 2005 Modelled IHME
0.08 (0.06 - 0.11) 2004 Modelled IHME
0.16 (0.12 - 0.22) 2003 Modelled IHME
0.26 (0.18 - 0.34) 2002 Modelled IHME
0.34 (0.24 - 0.44) 2001 Modelled IHME
0.38 (0.27 - 0.50) 2000 Modelled IHME
0.38 (0.28 - 0.51) 1999 Modelled IHME
0.39 (0.28 - 0.51) 1998 Modelled IHME
0.39 (0.29 - 0.52) 1997 Modelled IHME
0.4 (0.29 - 0.52) 1996 Modelled IHME
0.4 (0.29 - 0.53) 1995 Modelled IHME
0.4 (0.29 - 0.53) 1994 Modelled IHME
0.4 (0.29 - 0.53) 1993 Modelled IHME
0.4 (0.29 - 0.53) 1992 Modelled IHME
0.4 (0.29 - 0.54) 1991 Modelled IHME
0.4 (0.28 - 0.54) 1990 Modelled IHME
0.42 (0.05 - 3.53) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.12 (1.61 - 2.76) 2019 Modelled IHME
2.09 (1.58 - 2.71) 2018 Modelled IHME
2.05 (1.58 - 2.65) 2017 Modelled IHME
2.03 (1.58 - 2.61) 2016 Modelled IHME
1.96 (1.52 - 2.50) 2015 Modelled IHME
1.99 (1.55 - 2.54) 2014 Modelled IHME
2.1 (1.66 - 2.68) 2013 Modelled IHME
2.21 (1.73 - 2.83) 2012 Modelled IHME
2.29 (1.78 - 2.93) 2011 Modelled IHME
2.29 (1.78 - 2.93) 2010 Modelled IHME
2.24 (1.75 - 2.82) 2009 Modelled IHME
2.18 (1.70 - 2.74) 2008 Modelled IHME
2.09 (1.63 - 2.63) 2007 Modelled IHME
2.09 (1.65 - 2.62) 2006 Modelled IHME
2.07 (1.64 - 2.59) 2005 Modelled IHME
2.06 (1.61 - 2.58) 2004 Modelled IHME
2.09 (1.64 - 2.62) 2003 Modelled IHME
2.05 (1.61 - 2.58) 2002 Modelled IHME
2.04 (1.61 - 2.57) 2001 Modelled IHME
2.13 (1.67 - 2.67) 2000 Modelled IHME
2.21 (1.76 - 2.74) 1999 Modelled IHME
2.27 (1.81 - 2.82) 1998 Modelled IHME
2.37 (1.88 - 2.94) 1997 Modelled IHME
2.58 (2.07 - 3.20) 1996 Modelled IHME
2.67 (2.13 - 3.30) 1995 Modelled IHME
2.66 (2.13 - 3.29) 1994 Modelled IHME
2.69 (2.15 - 3.32) 1993 Modelled IHME
2.76 (2.20 - 3.42) 1992 Modelled IHME
2.81 (2.24 - 3.44) 1991 Modelled IHME
2.88 (2.29 - 3.53) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2 (2 - 3) 2019 Modelled IHME
2 (2 - 3) 2018 Modelled IHME
2 (2 - 3) 2017 Modelled IHME
2 (2 - 3) 2016 Modelled IHME
2 (2 - 3) 2015 Modelled IHME
2 (2 - 3) 2014 Modelled IHME
2 (2 - 3) 2013 Modelled IHME
2 (2 - 3) 2012 Modelled IHME
3 (2 - 3) 2011 Modelled IHME
3 (2 - 3) 2010 Modelled IHME
2 (2 - 3) 2009 Modelled IHME
2 (2 - 3) 2008 Modelled IHME
2 (2 - 3) 2007 Modelled IHME
2 (2 - 3) 2006 Modelled IHME
2 (2 - 3) 2005 Modelled IHME
2 (2 - 3) 2004 Modelled IHME
2 (2 - 3) 2003 Modelled IHME
2 (2 - 3) 2002 Modelled IHME
2 (2 - 3) 2001 Modelled IHME
2 (2 - 3) 2000 Modelled IHME
2 (2 - 3) 1999 Modelled IHME
3 (2 - 3) 1998 Modelled IHME
3 (2 - 3) 1997 Modelled IHME
3 (2 - 4) 1996 Modelled IHME
3 (2 - 4) 1995 Modelled IHME
3 (2 - 4) 1994 Modelled IHME
3 (2 - 4) 1993 Modelled IHME
3 (2 - 4) 1992 Modelled IHME
3 (2 - 4) 1991 Modelled IHME
3 (3 - 4) 1990 Modelled IHME
5 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
26 (19 - 35) 2019 Modelled IHME
26 (20 - 35) 2018 Modelled IHME
27 (20 - 35) 2017 Modelled IHME
27 (20 - 35) 2016 Modelled IHME
27 (20 - 35) 2015 Modelled IHME
27 (20 - 36) 2014 Modelled IHME
28 (21 - 36) 2013 Modelled IHME
28 (21 - 37) 2012 Modelled IHME
29 (22 - 37) 2011 Modelled IHME
29 (22 - 38) 2010 Modelled IHME
29 (23 - 38) 2009 Modelled IHME
29 (23 - 38) 2008 Modelled IHME
30 (23 - 38) 2007 Modelled IHME
30 (23 - 38) 2006 Modelled IHME
30 (23 - 38) 2005 Modelled IHME
30 (23 - 38) 2004 Modelled IHME
30 (23 - 38) 2003 Modelled IHME
30 (23 - 38) 2002 Modelled IHME
30 (23 - 38) 2001 Modelled IHME
29 (23 - 38) 2000 Modelled IHME
30 (23 - 38) 1999 Modelled IHME
29 (22 - 38) 1998 Modelled IHME
30 (22 - 38) 1997 Modelled IHME
29 (22 - 38) 1996 Modelled IHME
29 (22 - 38) 1995 Modelled IHME
29 (22 - 37) 1994 Modelled IHME
29 (22 - 38) 1993 Modelled IHME
29 (22 - 38) 1992 Modelled IHME
29 (22 - 38) 1991 Modelled IHME
29 (22 - 38) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
30 2017 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
31 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: MPP
Year of birth dose introduction
2017
Source: MPP
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.91 (1.56 - 2.36) 2019 Modelled IHME
1.9 (1.55 - 2.36) 2018 Modelled IHME
1.88 (1.52 - 2.35) 2017 Modelled IHME
1.85 (1.51 - 2.31) 2016 Modelled IHME
1.83 (1.49 - 2.26) 2015 Modelled IHME
1.81 (1.47 - 2.24) 2014 Modelled IHME
1.79 (1.46 - 2.23) 2013 Modelled IHME
1.78 (1.45 - 2.21) 2012 Modelled IHME
1.77 (1.42 - 2.20) 2011 Modelled IHME
1.75 (1.41 - 2.19) 2010 Modelled IHME
1.74 (1.40 - 2.16) 2009 Modelled IHME
1.72 (1.38 - 2.13) 2008 Modelled IHME
1.7 (1.37 - 2.11) 2007 Modelled IHME
1.68 (1.36 - 2.09) 2006 Modelled IHME
1.68 (1.35 - 2.08) 2005 Modelled IHME
1.68 (1.36 - 2.09) 2004 Modelled IHME
1.69 (1.36 - 2.09) 2003 Modelled IHME
1.7 (1.36 - 2.11) 2002 Modelled IHME
1.71 (1.36 - 2.12) 2001 Modelled IHME
1.72 (1.36 - 2.14) 2000 Modelled IHME
1.73 (1.38 - 2.15) 1999 Modelled IHME
1.74 (1.39 - 2.16) 1998 Modelled IHME
1.75 (1.41 - 2.18) 1997 Modelled IHME
1.76 (1.42 - 2.20) 1996 Modelled IHME
1.77 (1.42 - 2.21) 1995 Modelled IHME
1.78 (1.42 - 2.22) 1994 Modelled IHME
1.79 (1.44 - 2.23) 1993 Modelled IHME
1.79 (1.44 - 2.23) 1992 Modelled IHME
1.8 (1.44 - 2.24) 1991 Modelled IHME
1.8 (1.43 - 2.24) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.95 (2.90 - 5.27) 2019 Modelled IHME
3.9 (2.87 - 5.12) 2018 Modelled IHME
3.83 (2.87 - 5.04) 2017 Modelled IHME
3.79 (2.87 - 4.96) 2016 Modelled IHME
3.63 (2.77 - 4.71) 2015 Modelled IHME
3.45 (2.64 - 4.45) 2014 Modelled IHME
3.21 (2.49 - 4.13) 2013 Modelled IHME
3 (2.34 - 3.84) 2012 Modelled IHME
2.82 (2.19 - 3.62) 2011 Modelled IHME
2.74 (2.14 - 3.51) 2010 Modelled IHME
2.67 (2.08 - 3.43) 2009 Modelled IHME
2.61 (2.07 - 3.35) 2008 Modelled IHME
2.51 (1.97 - 3.19) 2007 Modelled IHME
2.52 (1.96 - 3.21) 2006 Modelled IHME
2.52 (1.96 - 3.21) 2005 Modelled IHME
2.51 (1.96 - 3.23) 2004 Modelled IHME
2.53 (1.98 - 3.23) 2003 Modelled IHME
2.5 (1.95 - 3.18) 2002 Modelled IHME
2.49 (1.95 - 3.18) 2001 Modelled IHME
2.6 (2.02 - 3.32) 2000 Modelled IHME
2.68 (2.06 - 3.39) 1999 Modelled IHME
2.73 (2.12 - 3.47) 1998 Modelled IHME
2.8 (2.16 - 3.54) 1997 Modelled IHME
2.95 (2.29 - 3.74) 1996 Modelled IHME
3.02 (2.36 - 3.81) 1995 Modelled IHME
3.07 (2.38 - 3.85) 1994 Modelled IHME
3.1 (2.44 - 3.89) 1993 Modelled IHME
3.16 (2.50 - 3.93) 1992 Modelled IHME
3.21 (2.53 - 4.01) 1991 Modelled IHME
3.28 (2.59 - 4.08) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4 (3 - 6) 2019 Modelled IHME
4 (3 - 6) 2018 Modelled IHME
4 (3 - 6) 2017 Modelled IHME
4 (3 - 6) 2016 Modelled IHME
4 (3 - 5) 2015 Modelled IHME
4 (3 - 5) 2014 Modelled IHME
4 (3 - 5) 2013 Modelled IHME
3 (3 - 4) 2012 Modelled IHME
3 (2 - 4) 2011 Modelled IHME
3 (2 - 4) 2010 Modelled IHME
3 (2 - 4) 2009 Modelled IHME
3 (2 - 4) 2008 Modelled IHME
3 (2 - 4) 2007 Modelled IHME
3 (2 - 4) 2006 Modelled IHME
3 (2 - 4) 2005 Modelled IHME
3 (2 - 4) 2004 Modelled IHME
3 (2 - 4) 2003 Modelled IHME
3 (2 - 3) 2002 Modelled IHME
3 (2 - 3) 2001 Modelled IHME
3 (2 - 4) 2000 Modelled IHME
3 (2 - 4) 1999 Modelled IHME
3 (2 - 4) 1998 Modelled IHME
3 (2 - 4) 1997 Modelled IHME
3 (3 - 4) 1996 Modelled IHME
3 (3 - 4) 1995 Modelled IHME
3 (3 - 4) 1994 Modelled IHME
3 (3 - 4) 1993 Modelled IHME
3 (3 - 4) 1992 Modelled IHME
4 (3 - 4) 1991 Modelled IHME
4 (3 - 4) 1990 Modelled IHME
2 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (14 - 28) 2019 Modelled IHME
21 (15 - 28) 2018 Modelled IHME
21 (15 - 28) 2017 Modelled IHME
21 (15 - 29) 2016 Modelled IHME
21 (15 - 29) 2015 Modelled IHME
21 (15 - 29) 2014 Modelled IHME
21 (15 - 29) 2013 Modelled IHME
22 (15 - 29) 2012 Modelled IHME
22 (15 - 29) 2011 Modelled IHME
22 (15 - 29) 2010 Modelled IHME
22 (15 - 29) 2009 Modelled IHME
22 (15 - 29) 2008 Modelled IHME
22 (15 - 29) 2007 Modelled IHME
22 (15 - 29) 2006 Modelled IHME
22 (16 - 29) 2005 Modelled IHME
22 (16 - 29) 2004 Modelled IHME
22 (16 - 29) 2003 Modelled IHME
22 (16 - 29) 2002 Modelled IHME
22 (16 - 29) 2001 Modelled IHME
22 (16 - 29) 2000 Modelled IHME
22 (16 - 29) 1999 Modelled IHME
22 (16 - 29) 1998 Modelled IHME
22 (16 - 30) 1997 Modelled IHME
22 (16 - 30) 1996 Modelled IHME
23 (16 - 30) 1995 Modelled IHME
23 (16 - 31) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
24 (17 - 31) 1992 Modelled IHME
24 (17 - 32) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: MPP
Year of birth dose introduction
2017
Source: MPP
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.52 (%)
2019
(0.44 - 0.61(%))
IHME
HCV (RNA/cAg+)
1.91 (%)
2019
(1.56 - 2.36(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2
2019
(2 - 3)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4
2019
(3 - 6)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.02 (%)
2019, latest modelled
(0.01 - 0.03(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources